Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

| --- | --- |

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Bryan Hanson
Dated: February 22, 2021		Bryan Hanson
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE
/s/ Bryan Hanson	President, Chief Executive Officer and Director	February 22, 2021
Bryan Hanson	(Principal Executive Officer)

/s/ Suketu Upadhyay	Executive Vice President and Chief Financial Officer	February 22, 2021
Suketu Upadhyay	(Principal Financial Officer)

/s/ Carrie Nichol	Vice President, Controller and Chief Accounting Officer	February 22, 2021
Carrie Nichol	(Principal Accounting Officer)

/s/ Christopher Begley	Director	February 22, 2021
Christopher Begley

/s/ Betsy Bernard	Director	February 22, 2021
Betsy Bernard

/s/ Gail Boudreaux	Director	February 22, 2021
Gail Boudreaux

/s/ Michael Farrell	Director	February 22, 2021
Michael Farrell

/s/ Larry Glasscock	Director	February 22, 2021
Larry Glasscock

/s/ Robert Hagemann	Director	February 22, 2021
Robert Hagemann

/s/ Arthur Higgins	Director	February 22, 2021
Arthur Higgins

/s/ Maria Teresa Hilado	Director	February 22, 2021
Maria Teresa Hilado

/s/ Syed Jafry	Director	February 22, 2021
Syed Jafry

	Director	February 22, 2021
Sreelakshmi Kolli

/s/ Michael Michelson	Director	February 22, 2021
Michael Michelson

Previous: Item 15. Exhibits and Financial Statement Schedules